# The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis

> **NCT06022874** · — · UNKNOWN · sponsor: **Phoilex Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **OTHER:** Phoilex Releaf Gel

## Key facts

- **NCT ID:** NCT06022874
- **Lead sponsor:** Phoilex Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-15
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-10-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06022874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06022874, "The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06022874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*